Abstract:Objective To investigate the relationship between the microRNA-17 (miR-17), microRNA-490-3p (miR-490-3p) expression with the clinicopathological characteristics and prognosis in patients with Helicobacter pylori (Hp) induced gastric cancer.Methods From January 2012 to June 2014, the gastric tissue samples from the Hp-positive and Hp-negative gastric cancer patients were collected, and the real time quantitative PCR (qRT-PCR) assay was used to detect the expression levels of miR-17, miR-490-3p in tissue samples. The relationships of miR-17 and miR-490-3p expression in Hp-positive gastric cancer with the clinicopathological characteristics were analyzed. The Kaplan Meier survival curve was utilized to evaluate the relationship of miR-17 and miR-490-3p expression with the 5-year overall survival rate of Hp positive gastric cancer patients. The Cox regression model was used to analyze the risk factors for prognostic of Hp positive gastric cancer patients.Results In the cancer tissues of Hp-positive and Hp-negative gastric cancer, the relative expression of miR-17 were higher than those in adjacent normal tissues (P < 0.05), the relative expression of miR-490-3p were lower than those in adjacent normal tissues (P < 0.05). Pearson correlation test showed that there was no significant correlation between the expression of miR-17 and miR-490-3p in gastric cancer tissue (P > 0.05). In Hp-positive gastric cancer tissues, there were statistical significance of the miR-17 expressions compared in different samples of patients with tumor diameter, lymph node metastasis, distance metastasis, and TNM stages (P < 0.05), there were statistical significance of the miR-490-3p expressions in samples of patients with different tumor diameter, lymph node metastasis, and distance metastasis (P < 0.05). Kaplan-Meier survival analysis showed that the 5-year overall survival rates of the miR-17 high-expression Hp-positive gastric cancer group and the miR-490-3p low-expression Hp-positive gastric cancer group were lower than those of the miR-17 low-expression Hp-positive gastric cancer group and the miR-490-3p high-expression Hp-positive gastric cancer group, respectively (P < 0.05). Multivariate Cox regression model suggests that, distance metastasis, high TNM stage, miR-17 high-expression, and miR-490-3p low-expression were risk factors affecting the prognosis of gastric cancer patients.Conclusion In HP-positive gastric cancer tissues, the miR-17 expression are increased, and miR-490-3p expression are decreased, which are related to worse clinicopathological parameters and poor prognosis. Monitoring the miR-17 and miR-490-3p expression in the cancer tissues may be useful in predicting the prognosis of patients.